Search results
Results from the WOW.Com Content Network
Survival rates are grouped based on how far the cancer has spread, but your age and overall health, the type of thyroid cancer you have, how well the cancer responds to treatment, and other factors can also affect your outlook.
For instance, early stage papillary thyroid cancer has a 5-year survival rate of more than 99%, but late stage anaplastic thyroid cancer has a 5-year survival rate of only 4%. The table...
This article discusses the prognosis for thyroid cancer, including survival rates by stage, type, age, and recurrence. It also looks at other factors that influence the outlook. Is thyroid...
The American Cancer Society’s most recent estimates for thyroid cancer in the United States are for 2024: About 44,020 new cases of thyroid cancer (12,500 in men and 31,520 in women) About 2,170 deaths from thyroid cancer (990 in men and 1,180 in women)
Rate of New Cases and Deaths per 100,000: The rate of new cases of thyroid cancer was 13.5 per 100,000 men and women per year. The death rate was 0.5 per 100,000 men and women per year. These rates are age-adjusted and based on 2017–2021 cases and 2018–2022 deaths.
The 5-year relative survival rates for each type of stage IV thyroid cancer are: Papillary thyroid cancer: Regional - 99%, Distant - 74%. Follicular thyroid cancer: Regional - 98%,...
The five-year survival rate for localized thyroid cancer is about 99.9 percent. Regional cancer has spread from the thyroid area to nearby lymph nodes. The five-year survival rate for regional thyroid cancer is about 98.3 percent.
Estimates put deaths caused by thyroid cancer at approximately 2,230 in 2022 (only 0.4% of cancer deaths). About 1.2% of people will be diagnosed with thyroid cancer during their lives. Almost 1 million people (915,664) were living with thyroid cancer in 2019, the institute's data reported.
Globally, in 2020, the age-standardised incidence rates of thyroid cancer were 10·1 per 100 000 women and 3·1 per 100 000 men, and age-standardised mortality rates were 0·5 per 100 000 women and 0·3 per 100 000 men.
Thyroid cancer incidence and mortality are expected to increase by 29.9% and 67%, respectively, by the year 2040. The African region is projected to experience the highest increase in both incidence (84.3%) and mortality (100.3%) over this time period.